scholarly journals Vibrationally excited populations from IR‐multiphoton absorption. I. Absorbed energy and reaction yield measurements

1985 ◽  
Vol 83 (12) ◽  
pp. 6251-6260 ◽  
Author(s):  
Jean‐Michel Zellweger ◽  
Trevor C. Brown ◽  
John R. Barker
Keyword(s):  
Reaction Yield ◽  
Multiphoton Absorption ◽  
Absorbed Energy ◽  
Vibrationally Excited

Formation mechanism of vibrationally excited O2 molecules in the multiphoton absorption of NO2

1986 ◽  
Vol 85 (9) ◽  
pp. 5061-5067 ◽  
Author(s):  
Kazuhiko Shibuya ◽  
Hidekazu Nagai ◽  
Takashi Imajo ◽  
Kinichi Obi ◽  
Ikuzo Tanaka
Keyword(s):  
Formation Mechanism ◽  
Multiphoton Absorption ◽  
Vibrationally Excited

Laser pulse duration effects in Xe2+ ions induced by multiphoton absorption at 0.53 μm

1983 ◽  
Vol 44 (11) ◽  
pp. 1247-1255 ◽  
Author(s):  
A. L'Huillier ◽  
L.A. Lompre ◽  
G. Mainfray ◽  
C. Manus
Keyword(s):  
Laser Pulse ◽  
Pulse Duration ◽  
Laser Pulse Duration ◽  
Multiphoton Absorption

Characterization of radioiodine therapy failures in Graves’ disease

2001 ◽  
Vol 40 (01) ◽  
pp. 1-6 ◽  
Author(s):  
M. Zimny ◽  
M. Schreckenberger ◽  
P. Reinartz ◽  
B. Nowak ◽  
E. Ostwald ◽  
...  
Keyword(s):  
Radioiodine Therapy ◽  
Thyroid Volume ◽  
Absorbed Dose ◽  
Stepwise Logistic Regression ◽  
Graves Disease ◽  
Significant Variable ◽  
Absorbed Energy ◽  
Volume Function ◽  
Energy Dose

Summary Aim of this study was a characterization of radioiodine therapy (RIT) failures in Graves’ disease without simultaneous Carbimazole. Method: 226 patients with a confirmed diagnosis of Graves’ disease received 686.8 ± 376.4 MBq of iodine-131 orally for thyroid ablation. Target dose was 250 Gy. All patients were followed up for 6 months. Therapy failures were compared with successes regarding possible influencing variables initial thyroid volume, thyroid function, immune activity (TRAb), 1-131 uptake, effective half-life, absorbed energy dose, age and gender. Results: 212 of 226 patients (93.8%) were treated successfully, 14 (6.2%) showed a hyperthyroidism relapse within 6 months which required a second radioiodine therapy. A success rate of 92.5% (62/67) could also be achieved with 67 patients who were hyperthyroid at the time of RIT. Compared to the therapy successes, the 14 failures achieved significantly lower absorbed doses (223.8 ±76.6 Gyvs. 285.2 ±82.1 Gy, ρ <0.005), but with no significant differences regarding age, thyroid volume, function or TRAb (all ρ >0.2). Of the 14 failures, η = 8 reached an absorbed dose <200 Gy and η = 1 a dose <250 Gy, although 5 of the failures reached an absorbed dose of >250 Gy. Stepwise logistic regression revealed only absorbed energy dose as a variable significantly influencing therapy success (p <0.005), but no influence of initial thyroid volume, function, TRAb value, age (all ρ >0.2) or gender (p = 0.13). Two-tailed Fisher’s exact test showed no significant influence of gender on success rates (failures/successes: male 1 /36, female 13/176, ρ = 0.48). Conclusions: Except for the absorbed energy dose, no other significant variable influencing the outcome of radioiodine therapy in Graves’ disease without simultaneous Carbimazole could be found. It should be noted, though, that 5 therapy failures (2.2%) reached an absorbed energy dose of >250 Gy.

Sign in / Sign up

Export Citation Format

Share Document